Everolimus EP Impurity D CAS 159351-69-67

Identification Properties Safety Data Specifications & Other Information Links Identification CAS Number 159351-69-67 Name Everolimus EP Impurity D Properties Appearance White Solid Safety Data RIDADR  NONH for all modes of transport WGK Germany 3 Specifications and Other Information of Our Everolimus EP Impurity D CAS 159351-69-67 Identification Methods HNMR, MS Purity 90% min Shelf Life…

Everolimus EP Impurity F CAS 159351-69-66

Everolimus EP Impurity F CAS 159351-69-66

Identification Properties Safety Data Specifications & Other Information Links Identification CAS Number 159351-69-66 Name Everolimus EP Impurity F Properties Appearance Off-white Solid Safety Data RIDADR  NONH for all modes of transport WGK Germany 3 Specifications and Other Information of Our Everolimus EP Impurity F CAS 159351-69-66 Identification Methods HNMR, MS Purity 95% min Shelf Life…

Everolimus EP Impurity C CAS 159351-69-64

Identification Properties Safety Data Specifications & Other Information Links Identification CAS Number 159351-69-64 Name Everolimus EP Impurity C Properties Appearance White Solid Safety Data RIDADR  NONH for all modes of transport WGK Germany 3 Specifications and Other Information of Our Everolimus EP Impurity C CAS 159351-69-64 Identification Methods HNMR, MS Purity 95% min Shelf Life…

Everolimus EP Impurity E CAS 1237826-25-3

Everolimus EP Impurity E CAS 1237826-25-3

Identification Properties Safety Data Specifications & Other Information Links Identification CAS Number 1237826-25-3 Name Everolimus EP Impurity E Synonyms (1R,2R)-4-{(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,28E,30S,32S,35R)-1,18-Dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hex atriaconta-16,24,26,28-tetraen-12-yl]propyl}-2-methoxycyclohexyl formate [ACD/IUPAC Name](1R,2R)-4-{(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,28E,30S,32S,35R)-1,18-Dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hex atriaconta-16,24,26,28-tetraen-12-yl]propyl}-2-methoxycyclohexylformiat [German] [ACD/IUPAC Name]23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, 3-[(1R)-2-[(3R,4R)-4-(formyloxy)-3-methoxycyclohexyl]-1-methylethyl]-9,10,12,13,14,21,22,23,24,25,26,27,32,3 3,34,34a-hexadecahydro-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-, (3S,6R,7E,9R,10R,12R,14S,15E,19E,21S,23S,26R,27R,34aS)- [ACD/Index Name]Formiate de (1R,2R)-4-{(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-diméthoxy-15,17,21,23,29,35-hexaméthyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3. ;1.04,9]hexatriaconta-16,24,26,28-tétraén-12-yl]propyl}-2-méthoxycyclohexyle [French] [ACD/IUPAC Name]1237826-25-3 [RN] SMILES CC1=CC=CC=C[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)C(C)=C[C@@H](C)C(=O)C[C@H](OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@H](C[C@@H]1OC)CC[C@H]2C)[C@H](C)CC1C[C@@H](OC)[C@@H](CC1)OC=O |c:1,t:5,20| StdInChI InChI=1S/C52H79NO14/c1-31-16-12-11-13-17-32(2)43(62-8)28-39-21-19-37(7)52(61,67-39)49(58)50(59)53-23-15-14-18-40(53)51(60)66-44(34(4)26-38-20-22-42(65-30-54)45(27-38)63-9)29-41(55)33(3)25-36(6)47(57)48(64-10)46(56)35(5)24-31/h11-13,16-17,25,30-31,33-35,37-40,42-45,47-48,57,61H,14-15,18-24,26-29H2,1-10H3/b13-11?,16-12+,32-17+,36-25+/t31-,33-,34-,35-,37-,38?,39+,40+,42-,43+,44+,45-,47-,48+,52-/m1/s1 StdInChIKey IUPNCBWADBCXHV-XONPCIIHSA-N Molecular Formula C52H79NO14 Molecular Weight 942.182 Properties Appearance…

Everolimus Impurity Everolimus-19-ene open ring(804-95) CAS 1062122-63-7

Everolimus Impurity Everolimus-19-ene open ring(804-95) CAS 1062122-63-7

Identification Properties Safety Data Specifications & Other Information Links Identification CAS Number 1062122-63-7 Name Everolimus Impurity Everolimus-19-ene open ring(804-95) Synonyms (2S)-1-{(2R,3R,6S)-2-Hydroxy-6-{(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3 ,5,7,15,19-docosapentaen-1-yl}-3-methyltetrahydro-2H-pyran-2-ylacetyl}-2-piperidincarbonsäure [German] [ACD/IUPAC Name](2S)-1-{(2R,3R,6S)-2-Hydroxy-6-{(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3 ,5,7,15,19-docosapentaen-1-yl}-3-methyltetrahydro-2H-pyran-2-ylacetyl}-2-piperidinecarboxylic acid [ACD/IUPAC Name]2-Piperidinecarboxylic acid, 1-[1,2-dioxo-2-[(2R,3R,6S)-tetrahydro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dim ethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl]-3-methyl-2H-pyran-2-yl]ethyl]-, (2S)- [ACD/Index Name]Acide (2S)-1-{2-[(2R,3R,6S)-2-hydroxy-6-{(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyéthoxy)-3-méthoxycyclohexyl]-2,13-diméthoxy-3,9,11,15,17,21-hexaméthyl-12,18 -dioxo-3,5,7,15,19-docosapentaén-1-yl}-3-méthyltétrahydro-2H-pyran-2-yl]-2-oxoacétyl}-2-pipéridinecarboxylique [French] [ACD/IUPAC Name](2S)?-1-?[2-?oxo-?2-?[(2R,?3R,?6S)?-?tetrahydro-?2-?hydroxy-?6-?[(2S,?3E,?5E,?7E,?9S,?11R,?13R,?14R,?15E,?17R,?19E,?21R)?-?14-?hydroxy-?22-?[(1S,?3R,?4R)?-?4-?(2-?hydroxyethoxy)?-?3-?methoxycyclohexyl]?-?2,?13-?dimethoxy-?3,?9,?11,?15,?17,?21-?hexamethyl-?12,?18-?dioxo-?3,?5,?7,?15,?19-?docosapentaen-?1-?yl]?-?3-?methyl-?2H-?pyran-?2-?yl]?acetyl]?-?2-?Piperidinecarboxylic acid1062122-63-7 [RN] SMILES C[C@@H]1CC[C@H](O[C@]1(C(=O)C(=O)N2CCCC[C@H]2C(=O)O)O)C[C@@H](/C(=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@@H]([C@@H](/C(=C/[C@@H](C)C(=O)/C=C/[C@H](C)C[C@@H]3CC[C@H]([C@@H](C3)OC)OCCO)/C)O)OC)/C)OC StdInChI InChI=1S/C53H83NO14/c1-33(16-12-11-13-17-35(3)45(64-8)32-41-22-20-39(7)53(63,68-41)50(59)51(60)54-25-15-14-18-42(54)52(61)62)28-37(5)47(57)49(66-10)48(58)38(6)30-36(4)43(56)23-19-34(2)29-40-21-24-44(67-27-26-55)46(31-40)65-9/h11-13,16-17,19,23,30,33-34,36-37,39-42,44-46,48-49,55,58,63H,14-15,18,20-22,24-29,31-32H2,1-10H3,(H,61,62)/b13-11+,16-12+,23-19+,35-17+,38-30+/t33-,34+,36-,37-,39-,40+,41+,42+,44-,45+,46-,48-,49+,53-/m1/s1 StdInChIKey PRSJHEVLVQFMHJ-FRLQEACCSA-N Molecular Formula C53H83NO14 Molecular Weight 958.224 Properties…